SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER .428 g/40mL
TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE · EMULSION · SHISEIDO AMERICAS CORPORATION
SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER is a emulsion containing titanium dioxide, octinoxate, and ensulizole at .428 g/40mL, taken topical. Manufactured by SHISEIDO AMERICAS CORPORATION.
Key Facts
- Brand Name
- SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER
- Generic Name
- TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE
- NDC Code (Product)
58411-657- Manufacturer
- SHISEIDO AMERICAS CORPORATION
- Strength
- .428 g/40mL
- Dosage Form
- EMULSION
- Route
- TOPICAL
- Marketing Status
- Application #
- M020
- Marketing Start
- 05/01/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER used for?
SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER contains TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE. It is a emulsion taken topical. Consult your doctor for specific uses.
Is SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER a controlled substance?
SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER is not classified as a controlled substance by the DEA.
What is the generic name for SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER?
The generic name for SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER is TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE. There are no other listed brand versions of TITANIUM DIOXIDE, OCTINOXATE, and ENSULIZOLE.
What is the NDC code for SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER .428 g/40mL?
The NDC (National Drug Code) for SHISEIDO FUTURE Solution LX INFINITE TREATMENT PRIMER .428 g/40mL is 58411-657, listed by SHISEIDO AMERICAS CORPORATION.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)